Entities / Company
OHT.
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 11
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around OHT this week
News at the entities that move OHT mostConnections
The 7 strongest of 11, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Lindsay Johnston Structural
Lindsay Johnston holds the formal role of Executive Director at OHT.
-
Jason Structural
Jason was appointed to lead OHT's business operations.
-
Patrick Mooney Operational
Patrick Mooney's company is developing a treatment specifically for OHT.
-
Bak Structural
OHT's products are implicated in causing ocular surface toxicity and inflammation in Bak.
-
O.D. Structural
O.D. oversees the clinical development process for OHT's treatments.
-
Johnston Shared context
OHT operates within a specific geographic context, which may be related to Johnston's sphere of influence.
-
Balkrishna Industries Mentioned together
No direct relationship between OHT and Balkrishna Industries is observed in the evidence.